{
    "clinical_study": {
        "@rank": "35166", 
        "brief_summary": {
            "textblock": "This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME)\n      in diabetic patients that undergo a DME screening exam.  The screening exam will consist of\n      medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus\n      photography"
        }, 
        "brief_title": "Identifying Patients With Unrecognized Treatable Diabetic Macular Edema", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetic Macular Edema", 
        "condition_browse": {
            "mesh_term": [
                "Edema", 
                "Macular Edema"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ability to provide written informed consent and comply with study assessments for the\n             full duration of the study\n\n          -  Age > 18 years\n\n          -  Patient related considerations\n\n          -  Patients with diabetes mellitus\n\n          -  Disease related considerations\n\n          -  Diabetes mellitus\n\n        Exclusion Criteria:\n\n          -  Prior admission screening within twelve months.\n\n          -  Inability to sit for evaluation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients identified through medical records or admitted into Franklin Square Hospital with\n        a history of diabetes"
            }
        }, 
        "enrollment": {
            "#text": "500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01934920", 
            "org_study_id": "Elman-01"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 3, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21237"
                }, 
                "name": "Franklin Square Hospital"
            }, 
            "investigator": {
                "last_name": "Michael J Elman, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "orr@elmanretina.com", 
            "last_name": "Peggy Orr, RN", 
            "phone": "410-686-3000"
        }, 
        "overall_contact_backup": {
            "email": "belz@elmanretina.com", 
            "last_name": "Jennifer L Belz", 
            "phone": "410-686-3000"
        }, 
        "overall_official": {
            "affiliation": "Elman Retina Group, P.A.", 
            "last_name": "Michael J Elman, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "This trial will assess the incidence of new and/or undiagnosed diabetic macular edema (DME) in diabetic patients that undergo a DME screening exam.  The screening exam will consist of medical history, Electronic ETDRS visual acuity assessment, SD-OCT and color fundus photography", 
            "measure": "Assess the incidence of new and/or undiagnosed diabetic macular edema.", 
            "safety_issue": "No", 
            "time_frame": "1 day (Patients are only seen once for assessments)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01934920"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Establish methods for streamlining screening and identification of patients at risk.\nEstablish methods for referral for treatment of patients identified with vision threatening diabetic retinopathy.", 
            "measure": "Streamlining and identification of patients at risk of diabetic macular edema", 
            "safety_issue": "No", 
            "time_frame": "1 day (Patients only seen once for assessments)"
        }, 
        "source": "Elman Retina Group", 
        "sponsors": {
            "collaborator": {
                "agency": "Genentech", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Elman Retina Group", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}